Calamos Advisors’s LifeMD LFMD Stock Holding History

Calamos Advisors’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-39,857	Closed	-$543K	–	968
2025 Q2	$543K	Buy	+39,857	New	+$376K	﹤0.01%	739
2024 Q3	–	Sell	-57,413	Closed	-$394K	–	974
2024 Q2	$394K	Buy	+57,413	New	+$525K	﹤0.01%	722

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Calamos Advisors's LFMD Position: Q3 2025 in Review

Calamos Advisors sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 39,857 shares — an estimated $543K sold.

Calamos Advisors first reported a position in LFMD in Q2 2024 and held it in 2 quarters. The position peaked at $543K in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Calamos Advisors reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Calamos Advisors sold 39,857 LifeMD shares in Q3 2025, an estimated $543K.
Calamos Advisors first reported a position in LifeMD in Q2 2024 and held it in 2 quarters.
Calamos Advisors's LifeMD position peaked at $543K in Q2 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Calamos Advisors's 13F filing for Q3 2025, filed 20 Oct 2025.